|
"tseng t c"的相关文件
显示项目 506-515 / 534 (共54页)
<< < 45 46 47 48 49 50 51 52 53 54 > >>
每页显示[10|25|50]项目
| 臺大學術典藏 |
2018-09-10T09:16:57Z |
Nanoparticle uptake and gene transfer efficiency for MSCs on chitosan and chitosan-hyaluronan substrates
|
SHAN-HUI HSU;Tseng, T.-C.;Ho, T.-T.;Hsu, S.-H.;SHAN-HUI HSU; Hsu, S.-H.; Ho, T.-T.; Tseng, T.-C.; SHAN-HUI HSU |
| 臺大學術典藏 |
2018-09-10T08:41:24Z |
Effects of hepatitis B virus precore and basal core promoter mutations on the expression of viral antigens: Genotype B vs C
|
Liu, C.-J. ;Cheng, H.-R.; Chen, C.-L.; Chen, T.-C.; Tseng, T.-C.; Wang, Z.-L. ;Chen, P.-J. ;Liu, C.-H. ;Chen, D.-S.; Kao, J.-H.; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:31:41Z |
Effect of host and viral factors on hepatitis B e antigen-positive chronic hepatitis B patients receiving pegylated interferon-α-2a therapy
|
Tseng, T.-C. ;Yu, M.-L.; Liu, C.-J.; Lin, C.-L. ;Huang, Y.-W.; Hsu, C.-S.; Liu, C.-H.; Kuo, S.F.-T. ;Pan, C.J.-H. ;Yang, S.-S. ;Su, C.-W. ;Chen, P.-J.; Chen, D.-S.; Kao, J.-H.; YI-WEN HUANG; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:46Z |
Implications of hepatitis B virus genomic variations on treatment outcomes
|
Tseng, T.-C.;Liu, C.-J.;Kao, J.-H.; CHUN-JEN LIU; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:39Z |
Increased incidence of gastroesophageal reflux disease in patients with chronic hepatitis B virus infection
|
Hsu, C.-S.; Wang, C.-C.;Wang, P.-C.; Lin, H.H.; Tseng, T.-C.; Chen, C.-H.; Su, W.-C.; Liu, C.-J.; Chen, C.-L.; Lai, M.-Y.; Chen, P.-J.; Chen, D.-S.; Kao, J.-H.; CHUN-JEN LIU; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:39:48Z |
Association of baseline viral factors with response to lamivudine therapy in chronic hepatitis B patients with high serum alanine aminotransferase levels
|
Tseng, T.-C.;Liu, C.-J.;Wang, C.-C.;Chen, P.-J.;Lai, M.-Y.;Chen, D.-S.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:35:33Z |
Hepatitis B virus genotype B has an earlier emergence of lamivudine resistance than genotype C
|
Hsieh, T.-H.;Tseng, T.-C.;Liu, C.-J.;Lai, M.-Y.;Chen, P.-J.;Hsieh, H.-L.;Chen, D.-S.;Kao, J.-H.; CHUN-JEN LIU; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:06:09Z |
A higher alanine aminotransferase level correlates with earlier hepatitis B e antigen seroconversion in lamivudine-treated chronic hepatitis B patients
|
Tseng, T.-C.; Liu, C.-J.; Wang, C.-C.; Chen, P.-J.; Lai, M.-Y.; Kao, J.-H.; Chen, D.-S.; CHUN-JEN LIU; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:02:32Z |
Pegylated interferon-α-2a plus ribavirin for treatment-naive Asian patients with hepatitis C virus genotype 1 infection: A multicenter, randomized controlled trial
|
Liu, C.-H.;Liu, C.-J.;Lin, C.-.;Liang, C.-C.;Hsu, S.-J.;Yang, S.-S.;Hsu, C.-S.;Tseng, T.-C.;Wang, C.-C.;Lai, M.-Y.;Chen, J.-H.;Chen, P.-J.;Chen, D.-S.;Kao, J.-H.; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T06:33:21Z |
Sequential combination therapy for chronic hepatitis B: More challenges to be tackled [7]
|
Tseng, T.-C.;Liu, C.-J.;Kao, J.-H.; Tseng, TC; CHUN-JEN LIU; Liu, CJ; JIA-HORNG KAO; Kao, JH. |
显示项目 506-515 / 534 (共54页)
<< < 45 46 47 48 49 50 51 52 53 54 > >>
每页显示[10|25|50]项目
|
